Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Jan;43(1):359-67.
doi: 10.1128/iai.43.1.359-367.1984.

Exopolysaccharide production by viridans streptococci in experimental endocarditis

Exopolysaccharide production by viridans streptococci in experimental endocarditis

J Mills et al. Infect Immun. 1984 Jan.

Abstract

Light and electron microscopy with histochemical staining were used to estimate exopolysaccharide production by strains of viridans streptococci recovered from patients with endocarditis. Six strains were selected for study because they represented a wide range of in vitro polysaccharide production. By light microscopy, there was good agreement between three polysaccharide stains (ruthenium red, periodic acid-Schiff and calcifluor white) in the amount of glycocalyx produced, which ranged from minimal (0 to 1+) to maximal amounts (4+). Two strains selected for minimal (strain 1) and maximal (strain 6) in vitro exopolysaccharide production were studied after we used them to experimentally infect cardiac vegetations. Glycocalyx could be demonstrated surrounding organisms in cardiac vegetations, and the relative amounts produced were similar to those seen in vitro. Vegetations formed by glycocalyx-producing strains were also larger than those formed by glycocalyx-deficient strains. Viridans group streptococci which produce exopolysaccharide in vitro also do so within cardiac vegetations. The relationship of exopolysaccharide production to maintenance of endocardial infection is discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Annu Rev Microbiol. 1981;35:299-324 - PubMed
    1. Crit Rev Microbiol. 1981;8(4):303-38 - PubMed
    1. J Clin Invest. 1978 May;61(5):1394-404 - PubMed
    1. Can J Microbiol. 1981 Sep;27(9):910-7 - PubMed
    1. Br J Exp Pathol. 1972 Feb;53(1):50-3 - PubMed

Substances